Ensure Dosing for Cancer Patients
For cancer patients who are malnourished or at risk of malnutrition and unable to meet nutritional goals through diet alone, oral nutritional supplements like Ensure should be provided at 400-500 mL per day (typically 2 servings daily) to achieve meaningful clinical benefits in weight gain, fatigue reduction, and quality of life improvement.
Stepwise Approach to Nutritional Support
The ESPEN 2021 guidelines provide a clear hierarchy for nutritional intervention in cancer patients 1:
Step 1: Dietary Counseling First
- Begin with nutrition counseling to encourage intake of protein- and energy-rich foods
- Treat nutrition impact symptoms (nausea, taste changes, early satiety) that impair food intake
- An enriched diet is the preferred initial approach 1
Step 2: Add Oral Nutritional Supplements (ONS)
ONS like Ensure should be added when:
- Enriched diet alone fails to meet nutritional goals
- Patient is eating less than 50% of requirements for more than 1 week
- Patient is eating only 50-75% of requirements for more than 2 weeks 1
Step 3: Progress to Tube Feeding or Parenteral Nutrition
- Only if oral intake plus ONS remains inadequate 1
Evidence-Based Dosing Recommendations
The most recent high-quality meta-analysis 2 from 2025 demonstrates:
- Optimal dose for fatigue reduction: ≥400 mL/day of ONS
- Optimal dose for quality of life improvement: ≥500 mL/day of ONS
- Dose for albumin improvement: ≥200 mL/day
This translates to 2 servings of Ensure daily (most Ensure products come in 220-237 mL bottles), providing approximately 440-474 mL total.
Clinical benefits demonstrated:
- Weight gain: 1.18 kg improvement (WMD: 1.18 kg; 95% CI, 0.20 to 2.17) 2
- Significant reduction in fatigue scores 2
- Improved quality of life scores 2
- Mean compliance was 73.4% in clinical trials 3
Nutritional Targets to Achieve
When using Ensure or similar ONS, aim for these daily targets 1:
- Total energy: 25-30 kcal/kg/day
- Protein: 1.0-1.5 g/kg/day (minimum 1.0 g/kg/day per ESPEN strong recommendation)
- Higher protein formulations are preferable: A 2023 study showed that high-protein ONS (≥20% energy from protein) enabled 88% of cancer patients to meet ESPEN protein recommendations versus only 55% in controls 3
For insulin-resistant or weight-losing patients: Consider higher fat-to-carbohydrate ratio formulations to increase energy density and reduce glycemic load 1
Practical Implementation
Standard regimen:
- Ensure (or similar ONS): 1 bottle (220-237 mL) twice daily
- Consume between meals or as meal replacements if oral intake is severely limited
- Continue alongside regular food intake when possible
High-protein formulations (like Ensure Plus or Ensure Max Protein) are superior, as recent evidence shows they reduce complications by 101 fewer per 1,000 patients (OR: 0.62,95% CI: 0.48-0.81) and decrease hospital length of stay by 0.26 days 4.
Critical Caveats
Refeeding syndrome risk: If oral intake has been severely decreased for a prolonged period, increase nutrition slowly over several days with electrolyte monitoring (phosphate, potassium, magnesium) 1
Avoid restrictive diets: Do not use energy-restricting diets, ketogenic diets, or fasting approaches in malnourished cancer patients—these lack evidence and risk worsening malnutrition 1
High-dose vitamins/supplements: Discourage use beyond recommended daily allowances unless specific deficiencies are documented. High-dose vitamin supplementation has not shown benefit and may be harmful 1, 5
Duration: Continue ONS throughout cancer treatment and as long as nutritional risk persists. Studies show benefits with use ranging from 5 to 365 days 4
When ONS Is Insufficient
If the patient cannot tolerate or achieve adequate intake with 400-500 mL/day of ONS plus oral diet, escalate to enteral nutrition via feeding tube, and only use parenteral nutrition if enteral access is not feasible 1.